The Child‐Pugh‐Turcotte score (CPT), which requires measurement of five clinical and laboratory variables (prothrombin time; albumin values; presence and degree of encephalopathy; presence and degree of ascites; and bilirubin levels), should be performed before the start of any DAA treatment. The gene discussed is F2; the disease is Encephalopathy.